Acinetobacter baumannii Coordinates Urea Metabolism with Metal Import To Resist Host-Mediated Metal Limitation.
During infection, bacterial pathogens must adapt to a nutrient metal-limited environment that is imposed by the host. The innate immune protein calprotectin inhibits bacterial growth in vitro by chelating the divalent metal ions zinc (Zn2+, Zn) and manganese (Mn2+, Mn), but pathogenic bacteria are able to cause disease in the presence of this antimicrobial protein in vivo. One such pathogen is Acinetobacter baumannii, a Gram-negative bacterium that causes pneumonia and bloodstream infections that can be complicated by resistance to multiple antibiotics. A. baumannii inhibition by calprotectin is dependent on calprotectin Mn binding, but the mechanisms employed by A. baumannii to overcome Mn limitation have not been identified. This work demonstrates that A. baumannii coordinates transcription of an NRAMP family Mn transporter and a urea carboxylase to resist the antimicrobial activities of calprotectin. This NRAMP family transporter facilitates Mn accumulation and growth of A. baumannii in the presence of calprotectin. A. baumannii is found to utilize urea as a sole nitrogen source, and urea utilization requires the urea carboxylase encoded in an operon with the NRAMP family transporter. Moreover, urea carboxylase activity is essential for calprotectin resistance in A. baumannii Finally, evidence is provided that this system combats calprotectin in vivo, as deletion of the transporter impairs A. baumannii fitness in a mouse model of pneumonia, and this fitness defect is modulated by the presence of calprotectin. These findings reveal that A. baumannii has evolved mechanisms to subvert host-mediated metal sequestration and they uncover a connection between metal starvation and metabolic stress.


OBJECTIVE
Acinetobacter baumannii is a bacterium that causes bloodstream, wound, urinary tract, and pneumonia infections, with a high disease burden in intensive care units. Treatment of A. baumannii infection is complicated by resistance to most antibiotics in use today, and resistance to last-resort therapies has become commonplace. New treatments for A. baumannii infection are desperately needed, but our current understanding of the bacterial factors required to cause infection is limited. We previously found that the abundant innate immune protein calprotectin inhibits the growth of A. baumannii by withholding essential metals. Despite this, A. baumannii is still able to infect wild-type mice, which produce calprotectin during infection. Here, we identify factors employed by A. baumannii during infection to overcome calprotectin-mediated metal sequestration. Moreover, we expose a connection between metal starvation and metabolism that may be a "chink in the armor" of A. baumannii and lead to new treatment options.
Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Lillian J
LJ
Juttukonda
Departments of Biochemistry and Chemistry and Center for Structural Biology, Vanderbilt University, Nashville, Tennessee, USA.
Walter J
WJ
Chazin
Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA Tennessee Valley Healthcare Systems, U.S. Department of Veterans Affairs, Nashville, Tennessee, USA eric.skaar@vanderbilt.edu.
Eric P
EP
Skaar
Mol Microbiol. 2000 Mar;35(5):1065-78
10712688
Nucleic Acids Res. 2010 Jul;38(Web Server issue):W695-9
20439314
N Engl J Med. 2010 May 13;362(19):1804-13
20463340
Nucleic Acids Res. 2000 Jan 1;28(1):27-30
10592173
Nat Struct Mol Biol. 2014 Nov;21(11):990-6
25326704
Infect Immun. 2009 Apr;77(4):1596-605
19188358
Nat Rev Microbiol. 2012 Jul 16;10(8):525-37
22796883
Microbiol Spectr. 2015 Oct;3(5):null
26542036
Proteomics. 2014 Apr;14(7-8):820-8
23754577
Infect Immun. 2013 Sep;81(9):3395-405
23817615
Infect Immun. 2007 Dec;75(12):5597-608
17908807
Cell Host Microbe. 2016 Jun 8;19(6):826-36
27281572
J Biol Chem. 1956 Jan;218(1):97-106
13278318
Cell Host Microbe. 2011 Aug 18;10(2):158-64
21843872
Mol Microbiol. 2000 Jun;36(5):1085-100
10844693
Infect Immun. 1991 Jul;59(7):2470-5
2050411
Plasmid. 2006 Sep;56(2):112-23
16530832
J Biol Chem. 1991 Apr 25;266(12):7706-13
2019594
FEBS Lett. 1999 Jul 23;455(3):344-8
10437801
Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):3841-6
23431180
J Bacteriol. 2004 May;186(9):2532-9
15090492
PLoS Pathog. 2012;8(12):e1003068
23236280
Nucleic Acids Res. 2016 Jan 4;44(D1):D457-62
26476454
Infect Immun. 2006 Jan;74(1):504-15
16369007
Mol Microbiol. 2016 May;100(4):589-606
27150893
PLoS One. 2012;7(10):e48475
23144764
J Trace Elem Med Biol. 2002;16(1):15-25
11878748
Expert Rev Anti Infect Ther. 2015 May;13(5):567-73
25850806
Infect Immun. 2000 Jun;68(6):3594-600
10816517
Pharmacotherapy. 2015 Oct;35(10):949-62
26497481
Bacteriol Rev. 1957 Sep;21(3):195-213
13471458
J Am Chem Soc. 2013 Nov 27;135(47):17804-17
24245608
J Gen Microbiol. 1976 Mar;93(1):75-81
4579
Gastroenterology. 1990 Sep;99(3):697-702
2379775
BMC Evol Biol. 2011 Mar 29;11:80
21447149
PLoS Genet. 2014 Jun 26;10(6):e1004429
24968120
Infect Immun. 2000 Feb;68(2):443-8
10639402
Science. 2008 Feb 15;319(5865):962-5
18276893
J Exp Med. 1999 Sep 6;190(5):717-24
10477555
J Biol Chem. 2015 Jul 31;290(31):18991-8
26055713
Appl Environ Microbiol. 2005 Aug;71(8):4437-45
16085834
Nucleic Acids Res. 2005 Oct 07;33(17):5691-702
16214803
PLoS Pathog. 2011 Sep;7(9):e1002261
21980287
FEMS Microbiol Lett. 2005 Apr 1;245(1):61-5
15796980
Infect Control Hosp Epidemiol. 2013 Jan;34(1):1-14
23221186
J Biol Chem. 1972 Jul 10;247(13):4107-13
4556303
Mol Microbiol. 2009 Apr;72(2):399-409
19298371
J Bacteriol. 2014 Jul;196(14):2616-26
24816603
Bioinformatics. 2007 Nov 1;23(21):2947-8
17846036
Nat Chem Biol. 2015 Oct;11(10):765-71
26302479
J Biol Chem. 1972 Dec 10;247(23):7539-45
4564566
Mol Microbiol. 2015 Jul;97(2):216-28
25898914